• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Tufts CSDD Releases Findings from Diabetes Study

Article

Pharmaceutical Executive

September 26, 2016

According to results of a new study by the Tufts Center for the Study of Drug Development, the development process for new diabetes and non-diabetes endocrine drugs is riskier compared to all drug development. The study examined the development pathways and characteristics of 27 diabetes and 34 non-diabetes endocrine drugs.

Read the full release here

Recent Videos
Related Content
Gaugarin Oliver

AI in Pharma: Where, When, and How Executives are Considering it

Gaugarin Oliver
November 19th 2024
Article

As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

Mike Hollan
November 15th 2024
Article

Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.

The Leap Forward: Practical Gains for Pharma AI Use

The Leap Forward: Practical Gains for Pharma AI Use

Bianca Anghelina;Helen Merianos;Ruth Beadle
November 14th 2024
Article

Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.

Abby Reynolds

The Rise of Digital Platforms: Q&A with Abby Reynolds

Mike Hollan
November 14th 2024
Article

Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.

Passage to Asia: Early Access for Innovative Therapies

Passage to Asia: Early Access for Innovative Therapies

Bruce Liu
November 13th 2024
Article

Pharma looks to take advantage of expanded access programs across Asia-Pacific region.

Becky Upton

Security and Data Sharing: Q&A with The Pistoia’s Alliance’s Dr. Becky Upton

Mike Hollan
October 30th 2024
Article

The alliance’s president discusses the current state of data sharing, security concerns, and the adoption AI.